3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Interventions
Fulvestrant
3
Radiotherapy
2
Carboplatin
2
repotrectinib
1
neratinib
1
Vorinostat
1
Trastuzumab
1
Taxes
1
Sampling Studies
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Adjuvant
1
Radiation
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Mastectomy, Segmental
1
Mass Spectrometry
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
Immunohistochemistry
1
High-Energy Shock Waves
1
Gene Expression Profiling
1
Fluorescent Antibody Technique
1
Drugs, Generic
1
Drug Therapy
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Crizotinib
1
Counseling
1
Chromatography, Liquid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Lobular
×
Drugs, Generic
×
1 year
×
Clear all
NCT03620643
2025-10-30
ROLo
Royal Marsden NHS Foundation Trust
Phase 2
Completed
33 enrolled
13 charts